ATG003

· CoMentis

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ATG003, covering 2010-10-28 to 2010-11-23. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) [Phase 2]